Natrelle Silicone-Filled Breast Implants and Natrelle INSPIRA Silicone-Filled Breast Implants
Allergan · Decision date Sep 29, 2026
What did the FDA approve?
The FDA database entry records an approval decision dated September 29, 2026, for supplement S064 to PMA P020056, covering Natrelle Silicone-Filled Breast Implants and Natrelle INSPIRA Silicone-Filled Breast Implants from Allergan. The decision type is APPR, and the statement field describes the action as approval for revised labeling to include the results of the BIFS Arm study.
The supplement is classified as a Normal 180 Day Track with no user fee, and the stated reason is Labeling Change - PAS. The device category is a noninflatable, internal, silicone gel-filled breast prosthesis under product code FTR. The database fields do not state what specific labeling text changed, what the BIFS Arm study measured, or whether the results support any safety or effectiveness conclusion.
FDA approval order statement
approval for revised labeling to include the results of the BIFS Arm study.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 29, 2026
- FDA change category
- Labeling Change - PAS
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P020056/S064
- Regulatory pathway
- PMA supplement
- Applicant
- Allergan
- Product code
- FTR
- Decision code
- APPR
- Decision date
- Sep 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.
For the original device and its historical approval scope, see PMA P020056. Subsequent supplements may change the device or its indications.
FDA decision timeline
P020056 · Original PMA
NATRELLE SILICONE-FILLED BREAST IMPLANTS
P020056/S064 received
Application receipt date recorded by FDA.
P020056/S064 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P020056. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P020056
Explore the linked device profile
Other records with product code FTR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Sientra Silicone Gel Breast ImplantsP070004/S049 | Tiger Aesthetics Medical, LLC | PMA supplement | Nov 4, 2026 | FDA |
MemoryGel Breast ImplantsP030053/S093 | Mentor Corp. | PMA supplement | Oct 23, 2026 | FDA |
MemoryShape Breast ImplantsP060028/S063 | Mentor Worldwide, LLC | PMA supplement | Oct 23, 2026 | FDA |
| Motiva USA, LLC | PMA supplement | Oct 2, 2026 | FDA | |
| Motiva USA, LLC | PMA supplement | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Allergan
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2525 Dupont Dr., Irvine, CA, 92612
Sources and methodology
- Original FDA record: P020056/S064
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


